These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 15820956

  • 1. Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate.
    Espinet B, Oliveira AC, Boqué C, Domingo A, Alonso E, Solé F.
    Haematologica; 2005 Apr; 90(4):556-8. PubMed ID: 15820956
    [Abstract] [Full Text] [Related]

  • 2. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
    Jiang Q, Chen SS, Jiang B, Jiang H, Lu Y, Qiu JY, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
    [Abstract] [Full Text] [Related]

  • 3. Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.
    Medina J, Kantarjian H, Talpaz M, O'Brien S, Garcia-Manero G, Giles F, Rios MB, Hayes K, Cortes J.
    Cancer; 2003 Nov 01; 98(9):1905-11. PubMed ID: 14584073
    [Abstract] [Full Text] [Related]

  • 4. Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities.
    Pawarode A, Sait SN, Nganga A, Coignet LJ, Barcos M, Baer MR.
    Leuk Res; 2007 Nov 01; 31(11):1589-92. PubMed ID: 17391756
    [Abstract] [Full Text] [Related]

  • 5. The first case of Philadelphia chromosome-negative acute promyelocytic leukemia following imatinib for chronic myelogenous leukemia.
    Wakim JJ, Tirado CA, Dowell J, Chen W.
    Cancer Genet; 2012 Mar 01; 205(3):124-7. PubMed ID: 22469511
    [Abstract] [Full Text] [Related]

  • 6. The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.
    Mohamed AN, Pemberton P, Zonder J, Schiffer CA.
    Clin Cancer Res; 2003 Apr 01; 9(4):1333-7. PubMed ID: 12684401
    [Abstract] [Full Text] [Related]

  • 7. The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells.
    Deininger MW, Cortes J, Paquette R, Park B, Hochhaus A, Baccarani M, Stone R, Fischer T, Kantarjian H, Niederwieser D, Gambacorti-Passerini C, So C, Gathmann I, Goldman JM, Smith D, Druker BJ, Guilhot F.
    Cancer; 2007 Oct 01; 110(7):1509-19. PubMed ID: 17702093
    [Abstract] [Full Text] [Related]

  • 8. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.
    Terre C, Eclache V, Rousselot P, Imbert M, Charrin C, Gervais C, Mozziconacci MJ, Maarek O, Mossafa H, Auger N, Dastugue N, Talmant P, Van den Akker J, Leonard C, N'Guyen Khac F, Mugneret F, Viguié F, Lafage-Pochitaloff M, Bastie JN, Roux GL, Nicolini F, Maloisel F, Vey N, Laurent G, Recher C, Vigier M, Yacouben Y, Giraudier S, Vernant JP, Salles B, Roussi J, Castaigne S, Leymarie V, Flandrin G, Lessard M, France Intergroupe pour la Leucemie Myeloide Chronique.
    Leukemia; 2004 Aug 01; 18(8):1340-6. PubMed ID: 15190256
    [Abstract] [Full Text] [Related]

  • 9. Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.
    Lin Y, Bruyère H, Horsman DE, Pantzar T, Barnett MJ, Hogge DE, Nevill TJ, Nantel SH, Sutherland HJ, Toze CL, Shepherd JD, Lavoie JC, Song KW, Smith CA, Forrest DL.
    Cancer Genet Cytogenet; 2006 Oct 01; 170(1):16-23. PubMed ID: 16965950
    [Abstract] [Full Text] [Related]

  • 10. Clonal chromosomal abnormalities in the Philadelphia chromosome negative cells of chronic myeloid leukemia patients treated with imatinib.
    Guilbert-Douet N, Morel F, Le Bris MJ, Berthou C, Morice P, Bourquard P, Braekeleer MD.
    Leukemia; 2004 Jun 01; 18(6):1140-2. PubMed ID: 15085159
    [No Abstract] [Full Text] [Related]

  • 11. Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
    Drummond MW, Holyoake TL.
    Cancer; 2003 Oct 15; 98(8):1776-7; author reply 1777-8. PubMed ID: 14534900
    [No Abstract] [Full Text] [Related]

  • 12. Clonal chromosome aberrations in Philadelphia-negative cells from chronic myelocytic leukemia patients treated with imatinib mesylate: report of two cases.
    Herens C, Baron F, Croisiau C, Tassin F, Bours V.
    Cancer Genet Cytogenet; 2003 Nov 15; 147(1):78-80. PubMed ID: 14580776
    [Abstract] [Full Text] [Related]

  • 13. Trisomy 6 in a CML patient receiving imatinib mesylate therapy.
    Zámecníkova A, Al Bahar S, Ramesh P.
    Leuk Res; 2008 Sep 15; 32(9):1454-7. PubMed ID: 18294688
    [Abstract] [Full Text] [Related]

  • 14. Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment.
    Iacobucci I, Rosti G, Amabile M, Poerio A, Soverini S, Cilloni D, Testoni N, Abruzzese E, Montefusco E, Ottaviani E, Iuliano F, Russo D, Gobbi M, Alimena G, Martino B, Terragna C, Pane F, Saglio G, Baccarani M, Martinelli G.
    J Clin Oncol; 2006 Jan 20; 24(3):454-9. PubMed ID: 16421422
    [Abstract] [Full Text] [Related]

  • 15. Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.
    Cortes J, Talpaz M, O'Brien S, Jones D, Luthra R, Shan J, Giles F, Faderl S, Verstovsek S, Garcia-Manero G, Rios MB, Kantarjian H.
    Clin Cancer Res; 2005 May 01; 11(9):3425-32. PubMed ID: 15867244
    [Abstract] [Full Text] [Related]

  • 16. Beyond chronic myelogenous leukemia: potential role for imatinib in Philadelphia-negative myeloproliferative disorders.
    Cortes J, Kantarjian H.
    Cancer; 2004 May 15; 100(10):2064-78. PubMed ID: 15139047
    [Abstract] [Full Text] [Related]

  • 17. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
    Pienkowska-Grela B, Woroniecka R, Solarska I, Kos K, Pastwińska A, Konopka L, Majewski M.
    Cancer Genet Cytogenet; 2007 Apr 15; 174(2):111-5. PubMed ID: 17452251
    [Abstract] [Full Text] [Related]

  • 18. Clonal karyotypic abnormalities in Philadelphia negative cells of CML patients treated with imatinib: is it under-reported and does it have any clinical significance?
    O'Shea D, Crotty G, Carroll P, Conneally E, McCann S, Neat MJ.
    Br J Haematol; 2004 Nov 15; 127(3):367-9. PubMed ID: 15491304
    [No Abstract] [Full Text] [Related]

  • 19. [Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR].
    Qin YZ, Ruan GR, Liu YR, Li JL, Fu JY, Wang H, Chang Y, Jiang B, Jiang Q, Jiang H, Qiu JY, Chen SS, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan 15; 26(1):1-5. PubMed ID: 15946498
    [Abstract] [Full Text] [Related]

  • 20. Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.
    Navarro JT, Feliu E, Grau J, Espinet B, Colomer D, Ribera JM, Oriol A, Granada I, Juncà J, Millá F.
    Am J Hematol; 2007 Sep 15; 82(9):849-51. PubMed ID: 17563075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.